Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
6.09
+0.24 (4.10%)
At close: Mar 9, 2026, 4:00 PM EDT
5.97
-0.12 (-1.97%)
After-hours: Mar 9, 2026, 6:29 PM EDT
Aardvark Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.02 | 0.02 |
| Net Debt / Equity Ratio | -1.03 | -1.01 | -1.08 | -0.99 |
| Net Debt / EBITDA Ratio | 2.35 | 3.20 | - | - |
| Net Debt / FCF Ratio | 2.78 | 4.01 | 1.69 | 1.50 |
| Quick Ratio | 11.77 | 14.95 | 7.23 | 27.07 |
| Current Ratio | 12.04 | 15.05 | 7.50 | 27.72 |
| Return on Equity (ROE) | -48.06% | -50.70% | -57.47% | - |
| Return on Assets (ROA) | -30.81% | -32.35% | -33.96% | - |
| Return on Capital Employed (ROCE) | -43.70% | -31.40% | -81.00% | -64.10% |
| Buyback Yield / Dilution | -282.40% | -0.90% | -1.78% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.